Annual EBITDA
-$384.86 M
-$4.38 M-1.15%
December 31, 2023
Summary
- As of February 7, 2025, AGIO annual EBITDA is -$384.86 million, with the most recent change of -$4.38 million (-1.15%) on December 31, 2023.
- During the last 3 years, AGIO annual EBITDA has fallen by -$58.74 million (-18.01%).
- AGIO annual EBITDA is now -2331.23% below its all-time high of -$15.83 million, reached on December 31, 2011.
Performance
AGIO EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$101.47 M
+$2.76 M+2.65%
September 30, 2024
Summary
- As of February 7, 2025, AGIO quarterly EBITDA is -$101.47 million, with the most recent change of +$2.76 million (+2.65%) on September 30, 2024.
- Over the past year, AGIO quarterly EBITDA has increased by +$2.76 million (+2.65%).
- AGIO quarterly EBITDA is now -2954.98% below its all-time high of $3.55 million, reached on September 30, 2014.
Performance
AGIO Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$401.29 M
-$2.19 M-0.55%
September 30, 2024
Summary
- As of February 7, 2025, AGIO TTM EBITDA is -$401.29 million, with the most recent change of -$2.19 million (-0.55%) on September 30, 2024.
- Over the past year, AGIO TTM EBITDA has dropped by -$2.19 million (-0.55%).
- AGIO TTM EBITDA is now -7925.76% below its all-time high of -$5.00 million, reached on March 31, 2012.
Performance
AGIO TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
AGIO EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -1.1% | +2.6% | -0.6% |
| 3 y3 years | -18.0% | -14.1% | -14.9% |
| 5 y5 years | -13.6% | +2.5% | -28.4% |
AGIO EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -4.3% | at low | -14.2% | +3.3% | -9.3% | at low |
| 5 y | 5-year | -24.9% | at low | -1857.7% | +3.3% | -61.4% | at low |
| alltime | all time | -2331.2% | at low | -2955.0% | +5.9% | -7925.8% | at low |
Agios Pharmaceuticals EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$101.47 M(-2.6%) | -$401.29 M(+0.5%) |
| Jun 2024 | - | -$104.22 M(+14.9%) | -$399.10 M(+3.2%) |
| Mar 2024 | - | -$90.72 M(-13.5%) | -$386.76 M(+0.5%) |
| Dec 2023 | -$384.86 M(+1.2%) | -$104.87 M(+5.6%) | -$384.86 M(+2.0%) |
| Sep 2023 | - | -$99.27 M(+8.0%) | -$377.35 M(+2.8%) |
| Jun 2023 | - | -$91.89 M(+3.5%) | -$367.18 M(-0.9%) |
| Mar 2023 | - | -$88.82 M(-8.8%) | -$370.64 M(-2.6%) |
| Dec 2022 | -$380.48 M(+3.1%) | -$97.36 M(+9.3%) | -$380.48 M(-1.4%) |
| Sep 2022 | - | -$89.11 M(-6.5%) | -$385.75 M(+0.0%) |
| Jun 2022 | - | -$95.35 M(-3.4%) | -$385.58 M(+1.7%) |
| Mar 2022 | - | -$98.67 M(-3.9%) | -$379.11 M(+2.7%) |
| Dec 2021 | -$369.18 M(+13.2%) | -$102.63 M(+15.4%) | -$369.18 M(+5.7%) |
| Sep 2021 | - | -$88.94 M(+0.1%) | -$349.30 M(+3.2%) |
| Jun 2021 | - | -$88.87 M(+0.2%) | -$338.33 M(+2.4%) |
| Mar 2021 | - | -$88.74 M(+7.2%) | -$330.31 M(+1.3%) |
| Dec 2020 | -$326.13 M(+5.8%) | -$82.74 M(+6.1%) | -$326.13 M(+31.2%) |
| Sep 2020 | - | -$77.97 M(-3.6%) | -$248.56 M(-9.5%) |
| Jun 2020 | - | -$80.85 M(-4.4%) | -$274.68 M(-8.9%) |
| Mar 2020 | - | -$84.56 M(+1531.4%) | -$301.66 M(-3.5%) |
| Dec 2019 | -$308.18 M(-9.1%) | -$5.18 M(-95.0%) | -$312.59 M(-18.9%) |
| Sep 2019 | - | -$104.09 M(-3.5%) | -$385.40 M(+1.8%) |
| Jun 2019 | - | -$107.83 M(+12.9%) | -$378.67 M(+10.7%) |
| Mar 2019 | - | -$95.48 M(+22.4%) | -$342.05 M(+0.9%) |
| Dec 2018 | -$338.86 M | -$77.99 M(-19.9%) | -$338.86 M(-3.0%) |
| Sep 2018 | - | -$97.36 M(+36.7%) | -$349.34 M(+6.1%) |
| Jun 2018 | - | -$71.21 M(-22.8%) | -$329.38 M(-3.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2018 | - | -$92.29 M(+4.3%) | -$341.19 M(+8.5%) |
| Dec 2017 | -$314.36 M(+61.0%) | -$88.48 M(+14.3%) | -$314.36 M(+11.6%) |
| Sep 2017 | - | -$77.40 M(-6.8%) | -$281.57 M(+5.8%) |
| Jun 2017 | - | -$83.03 M(+26.8%) | -$266.25 M(+11.7%) |
| Mar 2017 | - | -$65.46 M(+17.5%) | -$238.38 M(+22.1%) |
| Dec 2016 | -$195.28 M(+69.3%) | -$55.69 M(-10.3%) | -$195.28 M(+8.9%) |
| Sep 2016 | - | -$62.08 M(+12.5%) | -$179.34 M(+14.5%) |
| Jun 2016 | - | -$55.17 M(+146.8%) | -$156.69 M(+17.9%) |
| Mar 2016 | - | -$22.35 M(-43.8%) | -$132.88 M(+15.2%) |
| Dec 2015 | -$115.36 M(+118.6%) | -$39.75 M(+0.8%) | -$115.36 M(+13.1%) |
| Sep 2015 | - | -$39.43 M(+25.8%) | -$101.97 M(+72.9%) |
| Jun 2015 | - | -$31.35 M(+549.8%) | -$58.99 M(+29.3%) |
| Mar 2015 | - | -$4.83 M(-81.7%) | -$45.64 M(-13.5%) |
| Dec 2014 | -$52.77 M(+40.9%) | -$26.36 M(-841.8%) | -$52.77 M(+37.8%) |
| Sep 2014 | - | $3.55 M(-119.7%) | -$38.30 M(-27.1%) |
| Jun 2014 | - | -$18.00 M(+50.6%) | -$52.55 M(+23.1%) |
| Mar 2014 | - | -$11.95 M(+0.4%) | -$42.70 M(+14.0%) |
| Dec 2013 | -$37.44 M(+71.6%) | -$11.90 M(+11.3%) | -$37.44 M(+18.1%) |
| Sep 2013 | - | -$10.69 M(+31.2%) | -$31.71 M(+22.9%) |
| Jun 2013 | - | -$8.15 M(+21.7%) | -$25.81 M(+9.8%) |
| Mar 2013 | - | -$6.70 M(+8.5%) | -$23.51 M(+7.8%) |
| Dec 2012 | -$21.82 M(+37.8%) | -$6.17 M(+28.9%) | -$21.82 M(+39.5%) |
| Sep 2012 | - | -$4.79 M(-18.1%) | -$15.64 M(+44.2%) |
| Jun 2012 | - | -$5.85 M(+17.0%) | -$10.85 M(+117.0%) |
| Mar 2012 | - | -$5.00 M | -$5.00 M |
| Dec 2011 | -$15.83 M | - | - |
FAQ
- What is Agios Pharmaceuticals annual EBITDA?
- What is the all time high annual EBITDA for Agios Pharmaceuticals?
- What is Agios Pharmaceuticals annual EBITDA year-on-year change?
- What is Agios Pharmaceuticals quarterly EBITDA?
- What is the all time high quarterly EBITDA for Agios Pharmaceuticals?
- What is Agios Pharmaceuticals quarterly EBITDA year-on-year change?
- What is Agios Pharmaceuticals TTM EBITDA?
- What is the all time high TTM EBITDA for Agios Pharmaceuticals?
- What is Agios Pharmaceuticals TTM EBITDA year-on-year change?
What is Agios Pharmaceuticals annual EBITDA?
The current annual EBITDA of AGIO is -$384.86 M
What is the all time high annual EBITDA for Agios Pharmaceuticals?
Agios Pharmaceuticals all-time high annual EBITDA is -$15.83 M
What is Agios Pharmaceuticals annual EBITDA year-on-year change?
Over the past year, AGIO annual EBITDA has changed by -$4.38 M (-1.15%)
What is Agios Pharmaceuticals quarterly EBITDA?
The current quarterly EBITDA of AGIO is -$101.47 M
What is the all time high quarterly EBITDA for Agios Pharmaceuticals?
Agios Pharmaceuticals all-time high quarterly EBITDA is $3.55 M
What is Agios Pharmaceuticals quarterly EBITDA year-on-year change?
Over the past year, AGIO quarterly EBITDA has changed by +$2.76 M (+2.65%)
What is Agios Pharmaceuticals TTM EBITDA?
The current TTM EBITDA of AGIO is -$401.29 M
What is the all time high TTM EBITDA for Agios Pharmaceuticals?
Agios Pharmaceuticals all-time high TTM EBITDA is -$5.00 M
What is Agios Pharmaceuticals TTM EBITDA year-on-year change?
Over the past year, AGIO TTM EBITDA has changed by -$2.19 M (-0.55%)